Reaction
Ductal Adenocarcinoma Of Pancreas reporting signals
As of the last recalculation, Ductal Adenocarcinoma Of Pancreas appears in 272 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is OXALIPLATIN (PRR 189.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Oxaliplatin | 110 | 189.8 | 190.1 |
| Fluorouracil Cream, 0.5% | 108 | 179.1 | 179.3 |
| Fluorouracil | 108 | 176.5 | 176.8 |
| Gemcitabine | 38 | 85.6 | 85.7 |
| Gemcitabine Hydrochloride | 41 | 69.4 | 69.5 |
| Irinotecan Hydrochloride | 6 | 36.5 | 36.5 |
| Olaparib | 5 | 18.6 | 18.6 |